Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study

Joana Torres, Geert R. D’Haens, Miguel Regueiro, Genoile Santana, Julian Panés, Séverine Vermeire, Sean Gardiner, Nicole Kulisek, Irene Modesto, Chinyu Su, Nervin Lawendy, Rajiv Mundayat, Jerome Paulissen, Marla C. Dubinsky

Open source

DOI: 10.1177/17562848251318849
Published: 2025-01
Container: Therapeutic Advances in Gastroenterology
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/17562848251318849,
  title = {Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study},
  author = {Joana Torres and Geert R. D’Haens and Miguel Regueiro and Genoile Santana and Julian Panés and Séverine Vermeire and Sean Gardiner and Nicole Kulisek and Irene Modesto and Chinyu Su and Nervin Lawendy and Rajiv Mundayat and Jerome Paulissen and Marla C. Dubinsky},
  year = {2025},
  journal = {Therapeutic Advances in Gastroenterology},
  doi = {10.1177/17562848251318849},
  url = {https://doi.org/10.1177/17562848251318849}
}

RIS

TY  - JOUR
TI  - Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study
AU  - Joana Torres
AU  - Geert R. D’Haens
AU  - Miguel Regueiro
AU  - Genoile Santana
AU  - Julian Panés
AU  - Séverine Vermeire
AU  - Sean Gardiner
AU  - Nicole Kulisek
AU  - Irene Modesto
AU  - Chinyu Su
AU  - Nervin Lawendy
AU  - Rajiv Mundayat
AU  - Jerome Paulissen
AU  - Marla C. Dubinsky
PY  - 2025
JO  - Therapeutic Advances in Gastroenterology
DO  - 10.1177/17562848251318849
UR  - https://doi.org/10.1177/17562848251318849
ER  -

APA

Torres, J., D’Haens, G. R., Regueiro, M., Santana, G., Panés, J., Vermeire, S., Gardiner, S., Kulisek, N., Modesto, I., Su, C., Lawendy, N., Mundayat, R., Paulissen, J., & Dubinsky, M. C. (2025). Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/17562848251318849

Source records

crossref · retrieved 2026-09-25T20:28:11.840Z